Capital Advantage, Inc. Pfizer Inc Transaction History
Capital Advantage, Inc.
- $547 Million
- Q1 2025
A detailed history of Capital Advantage, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Capital Advantage, Inc. holds 14,896 shares of PFE stock, worth $335,606. This represents 0.07% of its overall portfolio holdings.
Number of Shares
14,896
Previous 14,896
-0.0%
Holding current value
$335,606
Previous $395,000
4.56%
% of portfolio
0.07%
Previous 0.07%
Shares
30 transactions
Others Institutions Holding PFE
# of Institutions
3,366Shares Held
3.57BCall Options Held
106MPut Options Held
123M-
Vanguard Group Inc Valley Forge, PA519MShares$11.7 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$9.56 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$6.54 Billion0.31% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA155MShares$3.5 Billion0.78% of portfolio
-
Geode Capital Management, LLC Boston, MA121MShares$2.72 Billion0.25% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $126B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...